Jefferies Starts Minerva Neurosciences (NERV) at Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
- AMD shares fall amid AI chip sector selloff
- JetBlue shares fall amid American results, fuel cost concerns
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- LKQ posts Q3 loss, replaces CEO amid Europe struggles
JMP Securities Starts Minerva Neurosciences (NERV) at Market Outperform
July 28, 2014 8:04 AM EDTJMP Securities initiated coverage on Minerva Neurosciences (NASDAQ: NERV) with a Market Outperform rating and a price target of $16.00.
For an analyst ratings summary and ratings history on Minerva Neurosciences click here. For more ratings news on Minerva Neurosciences click here.
Shares of Minerva Neurosciences closed at $6.78 yesterday.
... MoreBaird Starts Minerva Neurosciences (NERV) at Outperform
July 28, 2014 7:31 AM EDTBaird initiates coverage on Minerva Neurosciences (NASDAQ: NERV) with a Outperform rating and a price target of $11.00.
Analyst Brian Skorney comments, "several shots on goal make Minerva an interesting opportunity, initiating at Outperform with an $11 price target. Despite the high inherent risk associated... More



